Severe Asthma

In this Healio video exclusive, Nicola A. Hanania, MD, MS, highlights presentations from the CHEST Annual Meeting discussing biologic choice — particularly tezepelumab — in patients with severe asthma.

In this Healio video exclusive, Nicola A. Hanania, MD, MS, discusses CHEST Annual Meeting presentations that focused on the role of dupilumab in asthma treatment.

In this Healio video exclusive, Nicola A. Hanania, MD, MS, discusses a CHEST Annual Meeting symposium in which he participated that addressed choice of biologic in severe asthma.

LOUISVILLE, Ky. — Sex, race and ethnicity were associated with varying biomarker test results among adults with severe asthma, according to a presentation at the American College of Allergy, Asthma & Immunology Annual Scientific Meeting.

Sandhya Khurana, MD, FCCP, spoke with Healio about key takeaways from the CHEST Annual Meeting that she plans to incorporate into her practice.

Sandhya Khurana, MD, FCCP, spoke with Healio about important highlights in the asthma space presented at CHEST 2022.

LOUISVILLE, Ky. — Patients with asthma had a greater risk for ischemic heart disease compared with those without asthma, according to speaker at the American College of Allergy, Asthma & Immunology Annual Scientific Meeting.

In this video, Sandhya Khurana, MD, FCCP, discusses highlights from her presentation on advances in severe asthma at CHEST Annual Meeting.

Sandhya Khurana, MD, FCCP, spoke with Healio about a panel discussion regarding updates in allergy for asthma from the CHEST Annual Meeting.

Patients with poorly controlled asthma and mucus plugs had significantly more airflow obstruction, type 2 inflammation and severe exacerbations, according to a study published in The Journal of Allergy and Clinical Immunology: In Practice.